We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Lymphopenia in COVID‐19: Therapeutic opportunities.
- Authors
Fathi, Nazanin; Rezaei, Nima
- Abstract
Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) is uncontrollably spread all over the world. The host immune responses strongly try to confront it with all the potential cells and cytokines. With chronically condition of SARS‐CoV‐2, natural killer cells and T cells become exhausted and decreasing their count leads to lymphopenia. Inability to eradicate the infected organ makes hyperinitiation of the immune system, which releases the excessive inflammatory cytokines to compensate the exhausted one as well as the low lymphocytes counts; it consequently leads to the cytokine storm syndrome. These mechanisms and the potential therapeutic targeting are discussed in this paper.
- Subjects
COVID-19; CYTOKINE release syndrome; CYTOTOXIC T cells; LYMPHOPENIA; SARS-CoV-2
- Publication
Cell Biology International, 2020, Vol 44, Issue 9, p1792
- ISSN
1065-6995
- Publication type
Article
- DOI
10.1002/cbin.11403